References
- Alvarez XA, Franco A, Fernandez L, Cacabelos R (1993): Effect of Anapsos on behaviour and brain cytokines in rats. Ann Psychiat 3: 329–341.
- Alvarez XA, Zas R, Lagares R (1995): Neuro immunomodula-tory and neutrophilic activity of anapsos: studies which laboratory animals. Ann Psychiat 5: 267–280.
- Cuellar C, Rodero M, Bolds F, Martinez AR (1997): The effects of Polypodium leucotomos extract on the specific antibody production patterns in BALB/c mice immunized with third stage larvae antigens of Anisakis simplex. Int J Pharmacog 35: 1–8.
- Dea MA, Rodero M, Rodriguez R, Bolds F, Martinez AR (1999): Modulation by Anapsos (Polypodium leucotomos extract) of the antibody responses against the nematode parasite Trichinella spiralis. Phytother Res 13: 566–570.
- Fernandez L, Alvarez XA, Sempere JM, Miguel JJ, Diaz J, Franco A, Cacabelos R (1997): Effects of anapsos on the activity of the enzyme Cu-Zn-superoxide dismutase in an animal model of neuronal degeneration. Met Find Exp Clin Pharmacol 19: 99–106.
- Gonzalez S, Pathak MA (1996): Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid per-oxidation, erythema and skin photosensitization by Polypodium leucotomos. Photodermatol Photoimmunol Photomed 12: 45–56.
- Hattori Y, Nakanishi N (1995): Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in vacterial lipipolysaccharide-treated J774 macrophages. Cell Immunol 165: 7–11.
- Hernán P, Hector N, Pacheco J(1974): A new agent (hydrophilic fraction of Polypodium leucotomos) for management of psoriasis. Int J Dermatol 13: 342–347.
- Horvath A, Alvarado F, Szös J, de Alvarado ZN, Padilla G (1967): Metabolic effects of calagualine, an antitumoral saponine of Polypodium leucotomos. Nature 214: 1256–1258.
- Jimenez D, Doblare E, Naranjo R, Munoz C, Vargas J (1986): Anapsos modifies immunological parameters and improves the clinical course in atopic dermatitis. Dermatologica 173: 154–156.
- Jimenez D, Naranjo R, Doblare E, Munoz C, Vargas JF (1987): Anapsos an antopsoriatic drug, in atopic dermatitis. Allergol Inmunopathol 15: 185–189.
- Mohamad A (1989): Vitiligo repigmentation with Anapsos (Polypodium leucotomos). hit J Dermatol 28: 479.
- Sempere JM, Rodrigo C, Campos A, Villalba JF, Diaz J (1997): Effect of Anapsos (Polypodium leucotomos extract) on in vitro production of cytokines. Br J Clin Pharmacol 43: 85–89.
- Vargas J, Munoz C, Osorio C, Garcia E (1983): Anapsos an antipsoriatic drug which increases the proportion of supres-sor cells in human peripheral blood. Ann Immunol 134: 393–400.
- Vasange M, Bohlin L, Rolfsen W (1992): Effects of Calaguala and an active principle, adenosine, on platelet activating factor. Planta Med 58: 306–310.
- Vasange M, Liu B, Welch CJ, Rolfsen W, Bohlin L (1997a): The flavonoid constituents of two Polypodium species (Calaguala) and their effect on the elastase release in human neutrophils. Planta Med 6: 511–517.
- Vasange M, Rolfsen W, Bohlin L (1997b): A sulphonoglycolipid from the fern Polypodium decumanun and its effect on the platelet activating-factor receptor in human neutrophils. J Pharm Pharmacol 49: 562–566.